Skip to main navigation Skip to search Skip to main content

Mood changes associated with "end-of-dose deterioration" in Parkinson's disease: A controlled study

  • R. Cantello
  • , M. Gilli
  • , A. Riccio
  • , B. Bergamasco

Research output: Contribution to journalArticlepeer-review

Abstract

Fluctuations of mood and psychic activation were assessed in relation to "mobile" and "immobile" periods in 18 patients with Parkinson's disease presenting typical "end-of-dose deterioration". Twelve subjects with chronic but active rheumatoid arthritis presenting increased physical disability due to severe morning joint stiffness with a repetitive pattern of mobile and immobile periods acted as controls. The overall degree of disability and its fluctuations were close enough in the two groups for fair comparison of changes in affective behaviour. Temporary immobility was accompanied by adverse changes of mood and activation, which were significantly more marked in the Parkinson's disease group than in the controls, though to a lesser extent in those Parkinson's disease patients rated depressed even in their mobile periods. The possible correlation between mood changes and fluctuations of central dopaminergic function in the Parkinson's disease patients is discussed.

Original languageEnglish
Pages (from-to)1182-1190
Number of pages9
JournalJournal of Neurology, Neurosurgery and Psychiatry
Volume49
Issue number10
DOIs
Publication statusPublished - 1986
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Mood changes associated with "end-of-dose deterioration" in Parkinson's disease: A controlled study'. Together they form a unique fingerprint.

Cite this